West Pharmaceutical Services Inc (WST)
201.50
-1.70
(-0.84%)
USD |
NYSE |
Apr 07, 16:00
201.50
0.00 (0.00%)
After-Hours: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 14.57B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -47.24% |
| Valuation | |
| PE Ratio | 30.12 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 5.133 |
| Price to Book Value | 5.432 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.21 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0755 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 57.43% |
Profile
Edit
| West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States. |
| URL | https://www.westpharma.com |
| Investor Relations URL | https://www.westpharma.com/Investors |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Apr. 25, 2025 (est.) |
| Last Earnings Release | Feb. 13, 2025 |
| Next Ex-Dividend Date | Apr. 30, 2025 |
| Last Ex-Dividend Date | Feb. 07, 2025 |
Ratings
Profile
Edit
| West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States. |
| URL | https://www.westpharma.com |
| Investor Relations URL | https://www.westpharma.com/Investors |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Apr. 25, 2025 (est.) |
| Last Earnings Release | Feb. 13, 2025 |
| Next Ex-Dividend Date | Apr. 30, 2025 |
| Last Ex-Dividend Date | Feb. 07, 2025 |